Overview
Haruhiko Hirata practices in Suita, Japan. Hirata is rated as an Experienced expert by MediFind in the treatment of Lung Metastases. Their top areas of expertise are Emphysema, COVID-19, Small Cell Lung Cancer (SCLC), and Severe Acute Respiratory Syndrome (SARS).
Their clinical research consists of co-authoring 112 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 3 articles in the study of Lung Metastases.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- COVID-19Hirata isAdvanced. Learn about COVID-19.
- EmphysemaHirata isAdvanced. Learn about Emphysema.
- Lung CancerHirata isAdvanced. Learn about Lung Cancer.
- Severe Acute Respiratory Syndrome (SARS)
- Small Cell Lung Cancer (SCLC)
- Experienced
- Acute Interstitial PneumoniaHirata isExperienced. Learn about Acute Interstitial Pneumonia.
- AsthmaHirata isExperienced. Learn about Asthma.
- Castleman DiseaseHirata isExperienced. Learn about Castleman Disease.
- Cerebral HypoxiaHirata isExperienced. Learn about Cerebral Hypoxia.
- Chronic Eosinophilic PneumoniaHirata isExperienced. Learn about Chronic Eosinophilic Pneumonia.
- Chronic Obstructive Pulmonary Disease (COPD)